Insight Exchange by L.E.K. Consulting – Détails, épisodes et analyse

Today we look at how advanced therapeutic modalities (ATMs) are revolutionizing drug discovery, development and manufacturing, presenting both unparalleled opportunities and new challenges for businesses.

Drawing from their knowledge, our experts Alex Vadas, Adam Siebert and Jeff Holder unpack how new drug therapies such as engineered cell therapies, gene therapies and nucleic acid therapies are revolutionizing patient care and treatment options. They highlight the need for innovative business strategies to navigate complex manufacturing processes and supply chain logistics, the role of regulatory engagement, and the influence of artificial intelligence (AI) and machine learning in the realm of drug discovery.

Key points/topics covered:

• The transformative impact of new drug therapies on life sciences, requiring adaptations in business strategies
• The complexity of manufacturing for ATMs and its effect on the commercial viability of new treatments
• The importance of regulatory engagement in streamlining the drug development timeline for advanced therapies
• The intersection of AI and machine learning in expediting drug discovery for cell and gene therapies
• Manufacturing efficiency and supply chain consistency as a key differentiator in the outcomes and success rates of ATMs
  Interested in learning more? Read our Harvard Business Review article, A New Generation of Drug Therapies Requires New Business Strategies.

Connect with our experts on LinkedIn:
Alex Vadas, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/alexvadas/
Adam Siebert, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/adam-siebert-8772b327/
Jeff Holder, Managing Director, L.E.K. Consulting: https://www.linkedin.com/in/jeff-holder-ph-d-7a391087/

Visit L.E.K. Consulting at https://www.lek.com/

In today’s episode, we will focus on the influential trends and investment priorities shaping the specialty chemicals industry. Our subject matter experts will discuss the surge in innovation, digital transformation, and sustainability in the chemicals sector and highlight the strategic responses to recent industry challenges.

Key points/topics covered:

• Current investment trends and strategic priorities, such as innovation in alternative feedstocks and diversification in the specialty chemicals industry
• The implementation and impact of digital strategies, including operational efficiency and business growth, within chemical companies
• The significance of sustainability goals and consumer demand for sustainable products, which are driving specialty chemical manufacturers to innovate
• Actions taken by the chemical industry to promote more sustainable raw materials and leverage biosimilar opportunities and recycling
• Future directions for the chemicals industry, including addressing supply chain optimization and operational efficiency

To provide insights on these topics, you will hear from L.E.K. Consulting Managing Directors Carol Wingard, Peter Walter, Morgan Callahan and Amanda Davis Winters.

Interested in learning more? Read our Article, Key Issue Insights Into the Future of Specialty Chemicals.

Connect with our experts on LinkedIn:
Carol Wingard: https://www.linkedin.com/in/carolwingardlek/
Peter Walter: https://www.linkedin.com/in/peterwalterlek/
Morgan Callahan: https://www.linkedin.com/in/morganjcallahan/
Amanda Davis Winters: https://www.linkedin.com/in/adaviswinters/

Visit L.E.K. Consulting at https://www.lek.com/

This episode explores the challenges and opportunities of the coming year, focusing on macroeconomic headwinds, digital transformation, sustainability and generative AI. Partner and European region head Ben Faircloth and Chief Commercial Officer in Europe David Titus express optimism amid geopolitical complexities and market dynamics. The episode underscores L.E.K. Consulting’s deep sector capability and digital expertise, highlighting the need for agility and connectivity to provide clients with informed advice.

Key Points/Topics Covered:

1. Macroeconomic headwinds and market outlook for 2024

2. Digital transformation, data analytics and generative AI

3. Sustainability and resilience across sectors

4. Organisational capability building in volatile environments

5. Geopolitical complexities and regionalisation trends

Join us as we uncover the key themes, challenges and opportunities for the year ahead, and gain valuable insights into how L.E.K. is navigating these transformations to best support their clients.

Interested in learning more? Read our full series by visiting L.E.K. Look Forward into 2024.

Connect with our experts on LinkedIn:
Ben Faircloth, Partner and Head of the European region, L.E.K. Consulting: https://www.linkedin.com/in/benfaircloth/
David Titus, Chief Commercial Officer, Europe, L.E.K. Consulting: https://www.linkedin.com/in/davidtituslek/
Nick Portet, Creative Director, Wreyford: https://www.linkedin.com/in/nickportet/ 

Visit L.E.K. Consulting at https://www.lek.com/

The episode delves into the challenges faced by corporates in competitive acquisition processes and discusses strategies for corporate success in M&A. The main themes include the decline in success rates of corporates compared to financial investors, understanding the reasons behind this trend, and highlighting areas where corporates can adapt their approach to enhance their acquisition strategies.

Key points/topics covered:

• Volatility in M&A markets
• Challenges faced by corporates in competitive processes
• Strategies for corporate success in M&A
• Importance of governance and process in M&A
• Mitigating internal capability challenges

Join us for an in-depth conversation on strategic approaches to improve the customer acquisition journey and gain a competitive advantage in the M&A landscape.

Connect with our experts on LinkedIn:
Phil Roux, Partner, L.E.K. Consulting: https://www.linkedin.com/in/pgdroux/
Harpreet Singh, Partner, L.E.K. Consulting: https://www.linkedin.com/in/singharpreet/
Tom Marshall, Principal, L.E.K. Consulting: https://www.linkedin.com/in/tom-marshall-1078671b/

Visit L.E.K. Consulting at https://www.lek.com/

This episode explores the importance of digital capabilities and innovation culture in businesses. Darren Perry, Chuck Reynolds and Andy Main discuss how digital enables business model innovation, cross-functional collaboration, better customer service and differentiation from competitors. They emphasize the significance of trust, data-driven decision-making and the role of digital in improving the customer and employee experience. The episode also highlights the key factors that enable companies to become digital leaders and achieve success in their digital transformation journey.

Key points/topics covered:

• Importance of innovation culture and digital capabilities for businesses
• Cross-functional collaboration and connected enterprise enabled by digital
• Harnessing the power of the digital ecosystem for differentiation
• Measurement of success in digital transformation
• Personalization, data-driven decision-making and trust in the digital world

Throughout this engaging discussion, we discover how businesses are leveraging data analytics, embracing digital solutions and driving exciting changes in the market. Our experts provide detailed discussions and essential services to guide businesses through digital transformation.

Join us as we delve into the intricacies of the digital landscape and uncover the key elements that make a company a digital leader. Stay tuned for a deep dive into the L.E.K. Digital Impact Study and an exploration of the challenges faced as we navigate this ever-changing digital world.

Connect with our experts on LinkedIn:
Chuck Reynolds, Managing Director and Partner, L.E.K. Consulting: https://www.linkedin.com/in/cyreynolds/
Darren Perry, Managing Director and Partner, L.E.K. Consulting: https://www.linkedin.com/in/darrenperry/
Andy Main, Digital Leader and Advisor: https://www.linkedin.com/in/andymain/

Visit L.E.K. Consulting at https://www.lek.com/

On today’s episode, we are turning our attention to the complex and often misunderstood industry of restoration and remediation. Joining our host Gavin McGrath is Jonathan Ward, Operating Partner of Kohlberg, and Paul Bromfield, Partner at L.E.K. Consulting and expert in building and site services. Together, they will explore the inner workings of this multibillion-dollar industry, debunking misconceptions and shedding light on the true essence of restoration and remediation. From recurring events like burst pipes to the impact of extreme weather and insurance relationships, our guests will provide valuable insights and guidance on navigating this dynamic sector.

Key points/topics covered:

1. Revenue stability in the restoration and remediation industry
2. The impact of extreme weather and catastrophic events
3. The influence of insurance relationships on the industry

Connect with our experts on LinkedIn:
Paul Bromfield, Managing Director and Partner, L.E.K. Consulting: https://www.linkedin.com/in/paulbromfield/
Gavin McGrath, Managing Director and Partner, L.E.K. Consulting: https://www.linkedin.com/in/gavinmcgrath/
Jonathan Ward, Operating Partner, Kohlberg: https://www.linkedin.com/in/jonathan-ward-0667a57b/ 

Visit L.E.K. Consulting at https://www.lek.com/

Digital health has become one of those terms that mean everything and nothing at the same time. However, while opinions are varied on the exact impact and role digital health solutions will have on the healthcare ecosystem going forward, there is solid agreement that we all need to embrace digital in both clinical and nonclinical settings. How to do this, however, and which companies will be able to do so successfully, still remains to be seen.

L.E.K. Managing Director Sheila Shah and L.E.K. Manager Max Lounds are joined by Steve Sweeny and Sherie Zhou from Viz.ai to talk about their company’s solutions and how they’ve been able to successfully implement their digital vision and — importantly — why it’s working.

This episode explores how digital solutions, specifically AI-enabled workflows, are revolutionizing the healthcare industry. Steve and Sherie, experts in the field, discuss the pressing issue of improving patient access to care and the challenges faced by providers and life sciences companies. They delve into real-life case studies where AI and digital tools have played a crucial role in diagnosing, triaging and coordinating care for patients, ultimately leading to improved patient outcomes and increased market development opportunities for the industry.

Our guests share compelling case studies, including their work in ischemic stroke, cryptogenic stroke and hypertrophic cardiomyopathy. They also discuss how their AI-enabled solutions have revolutionized patient outcomes - by reducing diagnosis times from years to months - and the impact on improved care coordination.

Throughout the episode, our guests stress the importance of clinical workflows and the collaboration between AI and healthcare professionals. They address concerns about privacy and data security and highlight the need for AI to complement, not replace, human expertise. Ultimately, their goal is to empower clinicians, streamline processes and enhance the patient experience.

After listening to this episode, consider the various ways AI and digital solutions are transforming the healthcare industry. Share this episode with others to spread awareness of the potential benefits of and advancements in improving patient access to care.

Connect with our experts on LinkedIn:
Sheila Shah, Managing Director and Partner, L.E.K. Consulting: https://www.linkedin.com/in/sheilashah/
Maxwell Lounds, Engagement Manager, L.E.K. Consulting: https://www.linkedin.com/in/maxlounds/
Steve Sweeny, Vice President - Business Development & Strategy, Viz.ai: https://www.linkedin.com/in/steve-sweeny/
Sherie Zhou, Senior Manager - Commercial Strategy, Viz.ai: https://www.linkedin.com/in/sheriezhou/

Visit L.E.K. Consulting at https://www.lek.com/

Welcome to another episode of the L.E.K. Insight Exchange podcast, where we discuss the latest insights and ideas that are shaping the business landscape. In today's episode, our experts dive deep into the evolving U.S. healthcare delivery system and explore the potential changes that lie ahead. 
 
Today's host, L.E.K. Managing Director Frazer Dorey, is joined by three industry experts: Dr. Stephen Mansfield and L.E.K. Managing Directors Rozy Vig and Kevin Grabenstatter. Together, they share their insights on the current state of the U.S. healthcare provider landscape and offer their perspectives on how it might transform by 2035. 
 
Three key topics covered in this episode are: 

• Value-based care: The panel examines the growing traction of value-based care and its potential to drive positive change in healthcare pricing, quality and access. Our experts discuss the challenges associated with implementing value-based care initiatives and the need for a shift in treating chronically ill patients. 
• Transitioning to value-based care: With fee-for-service reimbursement still a significant source of revenue for hospitals and health systems, our experts discuss how executives in the healthcare industry should approach the transition to value-based care. They emphasize the importance of embracing this new model and encouraging physicians to follow proven care pathways. 
• Consolidation and new players: The conversation explores the trend of consolidation in the healthcare industry as well as the entry of new players into the provider landscape. The panel considers the implications of these changes and the role of scale in managing risk effectively. 

Join us for valuable insights from our panel of esteemed experts as we delve into this discussion on the future of the U.S. healthcare provider landscape and the potential impact of value-based care.

Connect with our experts on LinkedIn:
Kevin Grabenstatter, Managing Director, L.E.K. Consulting San Francisco office: https://www.linkedin.com/in/kgrabenstatter/
Frazer Dorey, Managing Director, L.E.K. Consulting New York office: https://www.linkedin.com/in/frazerdorey/
Rozy Vig, Managing Director, Healthcare Services L.E.K. Consulting San Francisco office: https://www.linkedin.com/in/rozyvig/
Dr. Stephen Mansfield, Dean of the College of Business of Dallas Baptist University: https://www.linkedin.com/in/stephen-mansfield-247946192/

Visit L.E.K. Consulting at https://www.lek.com/

This episode explores Gen Z shopping behavior and the key insights that brands and retailers should be aware of. Gen Z is constantly shopping and browsing online because their devices are always close at hand, yet they still value in-store experiences. They prioritize being informed and making every purchase count, often conducting extensive research before buying. Retailers that prioritize authenticity and provide a seamless online and offline experience are winning with Gen Z.

L.E.K. Consulting's Managing Director and Partner Chuck Reynolds is joined by two L.E.K. experts, Managing Director and Partner Laura Brookhiser and Managing Director and Partner Jen Wu, who provide valuable insights from their experiences and research. Together, they uncover four key findings about Gen Z's shopping habits, including their near-constant online shopping and browsing, their surprising appreciation for physical stores, their desire to be informed consumers, and their love for personal curation. By the end of this episode, you'll have a comprehensive understanding of how brands and retailers can capture Gen Z's attention and adapt to their unique preferences.

Connect with our experts on LinkedIn:
Chuck Reynolds, Managing Director and Partner, L.E.K. Consulting's Boston office: https://www.linkedin.com/in/cyreynolds/
Jen Wu, Managing Director and Partner, L.E.K. Consulting's New York office: https://www.linkedin.com/in/jenwulek/
Laura Brookhiser, Managing Director and Partner, L.E.K. Consulting's Boston office: https://www.linkedin.com/in/laura-brookhiser-6472b1b/

Visit L.E.K. Consulting at https://www.lek.com/

In today's episode, we dive deep into the world of gene therapies. Our host, Matt Mancuso, Managing Director and Partner at L.E.K. Consulting's Boston office, is joined by a panel of experts including Ellen Licking, Vice President of Consulting Services and Communications at Real Endpoints; Alex Guth, Managing Director at L.E.K.'s Boston office; and Roger Longman, Chairman of Real Endpoints. Together, they explore the challenges and opportunities surrounding the commercialization of and the access to gene therapies.

From the importance of patient support and access to care to the evolving landscape of value-based agreements, our guests share valuable insights during thought-provoking discussions from a recent gathering of key stakeholders in the gene therapy market. They cover topics such as the impact of combination therapies on efficacy evaluations, the need for infrastructure to enable data sharing, and the potential for risk-sharing structures to address uncertainties in gene therapy outcomes.

Through these conversations, they shed light on the current state of gene therapies, the hurdles that exist in their commercialization, and the innovative strategies being employed to overcome these obstacles. Join us as we explore the intricacies of gene therapies and gain a deeper understanding of the future possibilities and challenges that lie ahead.

Connect with our experts on LinkedIn:
Matt Mancuso: https://www.linkedin.com/in/matthewmancusophd/
Ellen Licking: https://www.linkedin.com/in/ellenlicking/
Alex Guth: https://www.linkedin.com/in/alex-guth-phd/
Roger Longman: https://www.linkedin.com/in/roger-longman-16ba079/

Visit L.E.K. Consulting at https://www.lek.com/